These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 31717651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence.
    Lestari B, Nakamae I, Yoneda-Kato N, Morimoto T, Kanaya S, Yokoyama T, Shionyu M, Shirai T, Meiyanto E, Kato JY.
    Sci Rep; 2019 Oct 16; 9(1):14867. PubMed ID: 31619723
    [Abstract] [Full Text] [Related]

  • 4. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H, Zhou BH, Qiu X, Wang HS, Zhang F, Fang R, Wang XF, Cai SH, Du J, Bu XZ.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2204-17. PubMed ID: 23085518
    [Abstract] [Full Text] [Related]

  • 5. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
    Chen X, Chen X, Zhang X, Wang L, Cao P, Rajamanickam V, Wu C, Zhou H, Cai Y, Liang G, Wang Y.
    Redox Biol; 2019 Feb 15; 21():101061. PubMed ID: 30590310
    [Abstract] [Full Text] [Related]

  • 6. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth.
    Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY.
    Sci Rep; 2018 Feb 01; 8(1):2039. PubMed ID: 29391517
    [Abstract] [Full Text] [Related]

  • 7. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
    Zou P, Xia Y, Chen T, Zhang J, Wang Z, Chen W, Chen M, Kanchana K, Yang S, Liang G.
    Mol Carcinog; 2016 Jun 01; 55(6):1073-86. PubMed ID: 26086416
    [Abstract] [Full Text] [Related]

  • 8. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
    Zhang T, Zheng P, Shen X, Shao R, Wang B, Shen H, Zhang J, Xia Y, Zou P.
    Free Radic Biol Med; 2019 Sep 01; 141():93-102. PubMed ID: 31176737
    [Abstract] [Full Text] [Related]

  • 9. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.
    Wang L, Wang C, Tao Z, Zhao L, Zhu Z, Wu W, He Y, Chen H, Zheng B, Huang X, Yu Y, Yang L, Liang G, Cui R, Chen T.
    J Exp Clin Cancer Res; 2019 Nov 08; 38(1):460. PubMed ID: 31703744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
    Li Q, Chen J, Luo S, Xu J, Huang Q, Liu T.
    Eur J Med Chem; 2015 Mar 26; 93():461-9. PubMed ID: 25728027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.
    Feng C, Xia Y, Zou P, Shen M, Hu J, Ying S, Pan J, Liu Z, Dai X, Zhuge W, Liang G, Ruan Y.
    Mol Carcinog; 2017 Jul 26; 56(7):1765-1777. PubMed ID: 28218464
    [Abstract] [Full Text] [Related]

  • 14. Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro.
    Leong SW, Chia SL, Abas F, Yusoff K.
    Eur J Med Chem; 2018 Sep 05; 157():716-728. PubMed ID: 30138803
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
    Wang L, Chen X, Du Z, Li G, Chen M, Chen X, Liang G, Chen T.
    J Exp Clin Cancer Res; 2017 Mar 31; 36(1):47. PubMed ID: 28359291
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
    Bayomi SM, El-Kashef HA, El-Ashmawy MB, Nasr MN, El-Sherbeny MA, Abdel-Aziz NI, El-Sayed MA, Suddek GM, El-Messery SM, Ghaly MA.
    Eur J Med Chem; 2015 Aug 28; 101():584-94. PubMed ID: 26197162
    [Abstract] [Full Text] [Related]

  • 18. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Park BH, Lim JE, Jeon HG, Seo SI, Lee HM, Choi HY, Jeon SS, Jeong BC.
    Oncotarget; 2016 Sep 27; 7(39):63870-63886. PubMed ID: 27564099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.